Chloroquine for Treatment of Glioblastoma Multiforme

Mise à jour : Il y a 4 ans
Référence : NCT00224978

Femme et Homme

  • | Pays :
  • Mexico
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Chloroquine is a strong lysosomotropic and DNA-intercalating agent in experimental studies (Neurosurgical Focus 14(2): February, 2003) and an open-label clinical trial the investigators have demonstrated a strong adjuvant effect of chloroquine on the therapy of malignant gliomas. This study will assess in a randomized, placebo-controlled, double-blind study the effects of chloroquine as adjuvant to the conventional therapy of Glioblastoma Multiforme.


Critère d'inclusion

  • Glioblastoma Multiforme

Liens